Erik Wennerberg

3.6k total citations · 1 hit paper
40 papers, 2.5k citations indexed

About

Erik Wennerberg is a scholar working on Immunology, Oncology and Physiology. According to data from OpenAlex, Erik Wennerberg has authored 40 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 25 papers in Oncology and 9 papers in Physiology. Recurrent topics in Erik Wennerberg's work include Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (16 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Erik Wennerberg is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (16 papers) and Cancer Immunotherapy and Biomarkers (15 papers). Erik Wennerberg collaborates with scholars based in United States, Sweden and United Kingdom. Erik Wennerberg's co-authors include Sandra Demaria, Silvia C. Formenti, Andreas Lundqvist, Nils-Petter Rudqvist, Claire Vanpouille‐Box, Claire Lhuillier, Karsten A. Pilones, Veronika Kremer, Ryan Emerson and Xi Kathy Zhou and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Erik Wennerberg

39 papers receiving 2.5k citations

Hit Papers

Radiotherapy induces responses of lung cancer to CTLA-4 b... 2018 2026 2020 2023 2018 200 400 600

Peers

Erik Wennerberg
Erik Wennerberg
Citations per year, relative to Erik Wennerberg Erik Wennerberg (= 1×) peers Nils-Petter Rudqvist

Countries citing papers authored by Erik Wennerberg

Since Specialization
Citations

This map shows the geographic impact of Erik Wennerberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Wennerberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Wennerberg more than expected).

Fields of papers citing papers by Erik Wennerberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Wennerberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Wennerberg. The network helps show where Erik Wennerberg may publish in the future.

Co-authorship network of co-authors of Erik Wennerberg

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Wennerberg. A scholar is included among the top collaborators of Erik Wennerberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Wennerberg. Erik Wennerberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fenton, Matthew J., Erik Wennerberg, Tom Lund, et al.. (2025). The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer. npj Breast Cancer. 11(1). 77–77.
2.
Provenzano, Elena, Sara Lightowlers, Selvakumar Anbalagan, et al.. (2024). Longitudinal Assessment of Tumor-Infiltrating Lymphocytes in Primary Breast Cancer Following Neoadjuvant Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 120(3). 862–874. 3 indexed citations
3.
Rudqvist, Nils-Petter, Maud Charpentier, Claire Lhuillier, et al.. (2023). Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors. Nature Communications. 14(1). 5146–5146. 32 indexed citations
4.
Rodríguez-Quintero, Jorge Humberto, et al.. (2023). Tumour immune escape via P2X7 receptor signalling. Frontiers in Immunology. 14. 1287310–1287310. 7 indexed citations
5.
Appleton, Elizabeth, Charleen Chan Wah Hak, Anna Wilkins, et al.. (2021). Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint Blockade. Frontiers in Immunology. 12. 754436–754436. 41 indexed citations
6.
Wennerberg, Erik, Sheila Spada, Nils-Petter Rudqvist, et al.. (2020). CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. Cancer Immunology Research. 8(4). 465–478. 103 indexed citations
7.
Wennerberg, Erik, Claire Lhuillier, Marissa Rybstein, et al.. (2020). Exercise reduces immune suppression and breast cancer progression in a preclinical model. Oncotarget. 11(4). 452–461. 84 indexed citations
8.
Spada, Sheila, Nils-Petter Rudqvist, & Erik Wennerberg. (2020). Isolation of DNA from exosomes. Methods in enzymology on CD-ROM/Methods in enzymology. 636. 173–183. 10 indexed citations
9.
Formenti, Silvia C., Nils-Petter Rudqvist, Encouse B. Golden, et al.. (2018). Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nature Medicine. 24(12). 1845–1851. 640 indexed citations breakdown →
10.
Rudqvist, Nils-Petter, Karsten A. Pilones, Claire Lhuillier, et al.. (2017). Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells. Cancer Immunology Research. 6(2). 139–150. 163 indexed citations
11.
Kremer, Veronika, et al.. (2017). Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 5(1). 73–73. 142 indexed citations
12.
Wennerberg, Erik, Claire Lhuillier, Claire Vanpouille‐Box, et al.. (2017). Barriers to Radiation-Induced In Situ Tumor Vaccination. Frontiers in Immunology. 8. 229–229. 152 indexed citations
13.
Lundqvist, Andreas, Yumeng Mao, Xiaonan Zhang, et al.. (2015). Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control. Journal for ImmunoTherapy of Cancer. 3(S2). 1 indexed citations
14.
Wennerberg, Erik, Aline Pfefferle, Lars Ekblad, et al.. (2014). Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell–Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells. Clinical Cancer Research. 20(22). 5733–5744. 50 indexed citations
15.
Wennerberg, Erik, Veronika Kremer, Richard Childs, & Andreas Lundqvist. (2014). CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo. Cancer Immunology Immunotherapy. 64(2). 225–235. 152 indexed citations
16.
Sarhan, Dhifaf, et al.. (2013). A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells. Cancer Immunology Immunotherapy. 62(8). 1359–1368. 27 indexed citations
17.
Mao, Yumeng, Isabel Poschke, Erik Wennerberg, et al.. (2013). Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms. Cancer Research. 73(13). 3877–3887. 157 indexed citations
18.
Wennerberg, Erik, Dhifaf Sarhan, Mattias Carlsten, et al.. (2013). Doxorubicin sensitizes human tumor cells to NK cell‐ and T‐cell‐mediated killing by augmented TRAIL receptor signaling. International Journal of Cancer. 133(7). 1643–1652. 49 indexed citations
19.
Kiessling, Rolf, Riki Okita, Dimitrios Mougiakakos, et al.. (2012). Opposing consequences of signaling through EGF family members. OncoImmunology. 1(7). 1200–1201. 2 indexed citations
20.
Okita, Riki, Dimitrios Mougiakakos, Takashi Ando, et al.. (2012). HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines. The Journal of Immunology. 188(5). 2136–2145. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026